Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of new Phase 3 ARTISTRY-1 and ARTISTRY-2 trial data at ...

In 2006, Gilead Sciences and Bristol Myers Squibb left a permanent mark on the HIV treatment paradigm by fusing together three antiretrovirals and creating the ...

WHO issued guidelines on July 14, 2025, recommending twice-yearly lenacapavir injections for HIV prevention, raising urgent questions for Nigeria’s response.

Dar es Salaam. Tanzania has officially registered Lenacapavir, a long-acting injectable drug for the prevention and control of HIV, marking what officials describe as a significant milestone in the ...

The Florida Department of Health has issued emergency rules that could sharply restrict access to HIV medications for thousands of residents.

New HIV research presented this week at the Conference on Retroviruses and Opportunistic Infections (CROI 2026) has revealed critical evidence gaps that experts say must be urgently addressed to ...

Phase 3 trial results show BIC/LEN is noninferior to BIC/FTC/TAF for maintaining virologic suppression in adults with HIV.

Starting Sunday, the state will cut its subsidies for the AIDS ​Drug Assistance Program (ADAP), and funds will only be available for people at or below 130% of the federal poverty level, a drop from ...

A bill moving through the Georgia General Assembly could allow trained pharmacists to prescribe PrEP, a daily medication that can prevent HIV.

Introduction Cryptococcal meningitis (CM) is an infection of the central nervous system that accounts for approximately 19% ...

Florida's proposed rule change to its AIDS Drug Assistance Program could cut off over 16,000 Floridians from life-saving ...

Last weekend, communities nationwide marked Black HIV/AIDS Awareness Day, or NBHAAD, during an urgent time for people living with the disease and those who support them. More than four decades after ...